BRIEF published on 04/02/2026 at 07:05, 3 hours 36 minutes ago BioVersys nomme Anca Cighi à la tête des relations avec les investisseurs Biopharmaceutique Relations Avec Les Investisseurs BioVersys Anca Cighi Résistant Aux Médicaments
BRIEF published on 04/02/2026 at 07:05, 3 hours 36 minutes ago BioVersys Names Anca Cighi as Head of Investor Relations Investor Relations Biopharmaceutical BioVersys Anca Cighi Drug-resistant
PRESS RELEASE published on 04/02/2026 at 07:00, 3 hours 41 minutes ago BioVersys Appoints Anca Cighi as Head of Investor Relations and Communications BioVersys AG appoints Anca Cighi as Head of Investor Relations and Communications. Anca brings 15 years of experience to the role Investor Relations Communications BioVersys AG Antibacterial Products Anca Cighi
BRIEF published on 03/31/2026 at 07:05, 2 days 3 hours ago BioVersys et Hackensack Meridian Health collaborent à la recherche sur les mycobactéries non tuberculeuses (MNT). Collaboration BioVersys Ansamycin Recherche Sur Les Mycobactéries Non Tuberculeuses Méridien De Hackensack
BRIEF published on 03/31/2026 at 07:05, 2 days 3 hours ago BioVersys and Hackensack Meridian Health Collaborate on NTM Research Collaboration BioVersys Ansamycin NTM Research Hackensack Meridian
PRESS RELEASE published on 03/31/2026 at 07:00, 2 days 3 hours ago BioVersys strengthens Ansamycin platform and NTM research through collaboration and license agreement with Hackensack Meridian Health BioVersys strengthens Ansamycin platform and NTM research through collaboration and license agreement with Hackensack Meridian Health Collaboration BioVersys NTM Ansamycin Hackensack Meridian Health
BRIEF published on 03/18/2026 at 07:05, 15 days 3 hours ago BioVersys dévoile ses réalisations et ses performances financières pour 2025 Résultats Financiers Essais Cliniques BioVersys Médicaments Antibactériens Financement Des Introductions En Bourse
BRIEF published on 03/18/2026 at 07:05, 15 days 3 hours ago BioVersys Unveils 2025 Achievements and Financial Performance Financial Results Clinical Trials BioVersys Antibacterial Drugs IPO Funding
PRESS RELEASE published on 03/18/2026 at 07:00, 15 days 3 hours ago BioVersys Reports Corporate Highlights and Financial Results for the Full Year 2025 BioVersys AG reports corporate highlights and financial results for the full year 2025, including significant progress in clinical and regulatory advancements of antibacterial products for MDR bacteria Financial Results BioVersys AG Antibacterial Products Clinical Progress Regulatory Advancements
BRIEF published on 03/16/2026 at 07:05, 17 days 3 hours ago BioVersys Gets FDA Nod for BV100 Phase 3 Trial for Pneumonia FDA Approval Phase 3 Trial BV100 BioVersys CRAB Infections
Published on 04/02/2026 at 09:00, 1 hour 41 minutes ago Algo Grande Reports Results from Completed Phase I Drill Program at Cerro Grande Skarn
Published on 04/02/2026 at 08:00, 2 hours 41 minutes ago Caledonia Mining Corporation Plc-Issue of Securities Pursuant to Long Term Incentive Plan Awards and Issue of New Long Term Incentive Plan Awards
Published on 04/02/2026 at 07:30, 3 hours 11 minutes ago Caldwell Expands Consumer Practice with Addition of Domenic Falzarano in Dubai
Published on 04/02/2026 at 04:00, 6 hours 41 minutes ago MedMira Reports Second Quarter Results FY2025
Published on 04/02/2026 at 00:55, 9 hours 46 minutes ago Silver Spruce Resources Inc. Announces Close of $739,250 First Tranche of Non-Brokered Private Placement and Extension
Published on 04/02/2026 at 10:30, 11 minutes ago Katjes International reports record revenue and earnings
Published on 04/02/2026 at 10:10, 31 minutes ago HIZENERGY Obtains TÜV SÜD Bankability Assessment, Solidifying Global Financing and Deployment Foundation for Energy Storage Projects
Published on 04/02/2026 at 10:00, 41 minutes ago Drill Success in Sonora: Algo Grande Reports Up to 3.9% Copper Equivalent
Published on 04/02/2026 at 09:17, 1 hour 24 minutes ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Published on 04/02/2026 at 09:00, 1 hour 41 minutes ago STEF : Avis de mise à disposition des comptes annuels 2025
Published on 04/02/2026 at 08:30, 2 hours 11 minutes ago Edenred and EnBW partner to simplify electric fleet management in Germany
Published on 04/02/2026 at 08:30, 2 hours 11 minutes ago Edenred et EnBW s'associent pour simplifier la gestion des flottes électriques en Allemagne
Published on 04/02/2026 at 08:05, 2 hours 36 minutes ago Neoen announces the launch of France's largest battery
Published on 04/02/2026 at 08:05, 2 hours 36 minutes ago Neoen annonce le lancement de la plus grande batterie de France
